Goldman Sachs Group »

Corvus Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Corvus Pharmaceuticals

2017201820192020202120222023202402M4M6M00.5M1M
Value ($)Share countHistorical CRVS position of Goldman Sachs Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $5.8M 1.1M 5.35
2024-09-30 $4.6M 876k 5.28
2023-09-30 $72k 49k 1.46
2023-06-30 $216k 94k 2.29
2022-06-30 $39k 40k 0.98
2022-03-31 $116k 71k 1.64
2021-12-31 $255k 106k 2.41
2021-09-30 $121k 25k 4.85
2021-03-31 $95k 31k 3.08
2020-12-31 $291k 82k 3.56
2020-09-30 $415k 104k 4.01
2020-06-30 $311k 114k 2.72
2019-12-31 $583k 107k 5.44
2019-09-30 $180k 60k 3.01
2019-06-30 $228k 61k 3.75
2019-03-31 $109k 27k 4.02
2018-12-31 $144k 39k 3.66
2018-09-30 $335k 39k 8.59
2018-06-30 $856k 78k 10.98
2018-03-31 $406k 35k 11.53
2017-12-31 $253k 24k 10.37
2016-12-31 $173k 12k 14.29
2016-09-30 $406k 25k 16.44
2016-06-30 $157k 11k 14.26
2016-03-31 $386k 27k 14.49